Aromatase inhibitors in the treatment of advanced breast cancerOSBORNE, C. Kent.Seminars in oncology. 1996, Vol 23, Num 4, issn 0093-7754, 39 p., SUP9Serial Issue

Aromatase inhibitors : Rationale for use following antiestrogen therapyYUE, W; SANTEN, R. J.Seminars in oncology. 1996, Vol 23, Num 4, pp 21-27, issn 0093-7754, SUP9Article

Aromatase inhibitors in clinical practice : Current status and a look to the futureHARVEY, H. A.Seminars in oncology. 1996, Vol 23, Num 4, pp 33-38, issn 0093-7754, SUP9Article

Optimizing Chemotherapy-Free Survival for the ER/HER2-Positive Metastatic Breast Cancer PatientGLÜCK, Stefan; ARTEAGA, Carlos L; OSBORNE, C. Kent et al.Clinical cancer research (Print). 2011, Vol 17, Num 17, pp 5559-5561, issn 1078-0432, 3 p.Article

Hormonal approaches to breast cancer treatment and prevention : An overviewVOGEL, C. L.Seminars in oncology. 1996, Vol 23, Num 4, pp 1-9, issn 0093-7754, 8 p., SUP9Article

Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family : Molecular Mechanism and Clinical Implications for Endocrine Therapy ResistanceARPINO, Grazia; WIECHMANN, Lisa; OSBORNE, C. Kent et al.Endocrine reviews. 2008, Vol 29, Num 2, pp 217-233, issn 0163-769X, 17 p.Article

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapyXIAOJIANG CUI; SCHIFF, Rachel; ARPINO, Grazia et al.Journal of clinical oncology. 2005, Vol 23, Num 30, pp 7721-7735, issn 0732-183X, 15 p.Article

Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databasesBARDOU, Valerie-Jeanne; ARPINO, Grazia; ELLEDGE, Richard M et al.Journal of clinical oncology. 2003, Vol 21, Num 10, pp 1973-1979, issn 0732-183X, 7 p.Article

Aromatase inhibitors : Future directionsOSBORNE, C. Kent; SCHIFF, Rachel.Journal of steroid biochemistry and molecular biology. 2005, Vol 95, Num 1-5, pp 183-187, issn 0960-0760, 5 p.Conference Paper

Aromatase inhibitors and breast cancerBRODIE, A. M. H; NJAR, V. C. O.Seminars in oncology. 1996, Vol 23, Num 4, pp 10-20, issn 0093-7754, SUP9Article

Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer : Research in Breast Cancer: Frontiers in Genomics, Biology, and Clinical InvestigationZHANG, Xiang H.-F; GIULIANO, Mario; TRIVEDI, Meghana V et al.Clinical cancer research (Print). 2013, Vol 19, Num 23, pp 6389-6397, issn 1078-0432, 9 p.Article

Low SAFB levels are associated with worse outcome in breast cancer patientsHAMMERICH-HILLE, Stephanie; BARDOUT, Valerie J; HILSENBECK, Susan G et al.Breast cancer research and treatment. 2010, Vol 121, Num 2, pp 503-509, issn 0167-6806, 7 p.Article

Aromatase inhibitors in metastatic breast cancerBUZDAR, A. U; PLOURDE, P. V; HORTOBAGYI, G. N et al.Seminars in oncology. 1996, Vol 23, Num 4, pp 28-32, issn 0093-7754, SUP9Article

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancerMA, Xiao-Jun; HILSENBECK, Susan G; WANG, Wilson et al.Journal of clinical oncology. 2006, Vol 24, Num 28, pp 4611-4619, issn 0732-183X, 9 p.Article

Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer : Treatment results of intergroup protocol INT-0102HUTCHINS, Laura F; GREEN, Stephanie J; RAVDIN, Peter M et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8313-8321, issn 0732-183X, 9 p.Conference Paper

Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: A multinational, double-blind, randomized trialHOWELL, Anthony; ROBERTSON, John F. R; OSBORNE, C. Kent et al.Journal of clinical oncology. 2004, Vol 22, Num 9, pp 1605-1613, issn 0732-183X, 9 p.Article

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trialALBAIN, Kathy S; BARLOW, William E; LICHTER, Allen S et al.Lancet (British edition). 2010, Vol 374, Num 9707, pp 2055-2063, issn 0140-6736, 9 p.Article

Epidermal Growth Factor Receptor Expression in Breast Cancer Association With Biologic Phenotype and Clinical OutcomesRIMAWI, Mothaffar F; SHETTY, Priya B; WEISS, Heidi L et al.Cancer. 2010, Vol 116, Num 5, pp 1234-1242, issn 0008-543X, 9 p.Article

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: Results from INT 0101 (E5188)DAVIDSON, Nancy E; O'NEILL, Anne M; VUKOV, Allen M et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 5973-5982, issn 0732-183X, 10 p.Conference Paper

Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 geneMARTIN, Michelle D; FISCHBACH, Kathy; OSBORNE, C. Kent et al.Cancer research (Baltimore). 2001, Vol 61, Num 9, pp 3578-3580, issn 0008-5472Conference Paper

Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapiesMARTIN, Michelle D; HILSENBECK, Susan G; MOHSIN, Syed K et al.Breast cancer research and treatment. 2006, Vol 95, Num 1, pp 7-12, issn 0167-6806, 6 p.Article

Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor- positive, HER-2/neu-positive breast cancerMASSARWEH, Suleiman; OSBORNE, C. Kent; SHOU JIANG et al.Cancer research (Baltimore). 2006, Vol 66, Num 16, pp 8266-8273, issn 0008-5472, 8 p.Article

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma : A prospectively planned combined survival analysis of two multicenter trialsHOWELL, Anthony; PIPPEN, John; ELLEDGE, Richard M et al.Cancer. 2005, Vol 104, Num 2, pp 236-239, issn 0008-543X, 4 p.Article

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patientsCHANG, Jenny C; WOOTEN, Eric C; CHAMNESS, Gary C et al.Journal of clinical oncology. 2005, Vol 23, Num 6, pp 1169-1177, issn 0732-183X, 9 p.Article

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancersTHAM, Yee-Lu; GOMEZ, L. Fernando; CHANG, Jenny C et al.Breast cancer research and treatment. 2005, Vol 94, Num 3, pp 279-284, issn 0167-6806, 6 p.Article